SETHI, Dalip,BAKER, Bruce,PONEMONE, Venkatesh,HARRIS, Kenneth, Lee,LACHER, Markud, D.,HEISERMAN, James
申请号：
EP16789796
公开号：
EP3288566A4
申请日:
2016.04.28
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Disclosed herein is methods, it improves or inhibits critical limb ischemia associated with the critical limb ischemia in a main body or a situation, therefore such method includes that mark has a main body of a peripheral vascular disease associated with critical limb ischemia, peripheral arterial disease, critical limb ischemia or a situation and provides the subject composition for including a: cell colony, wherein cell colony includes the total karyocyte and red blood cell of marrow, one anticoagulant, and self plasma, wherein composition has 1. measured at 37 degrees Celsius5 to 5.One viscosity of 0 centipoise (cP), wherein composition include a living cells dosage and, it includes multiple ports and a closed end that wherein the synthetic, which is administered to the subject or the side-ported needle of a casing or conduit in the ported remaining needle in end-by a standard with being located at muscle,.
